Ying Mu

1.5k total citations
23 papers, 1.2k citations indexed

About

Ying Mu is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Ying Mu has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Pharmacology and 5 papers in Oncology. Recurrent topics in Ying Mu's work include Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and HIV Research and Treatment (4 papers). Ying Mu is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and HIV Research and Treatment (4 papers). Ying Mu collaborates with scholars based in United States, China and New Zealand. Ying Mu's co-authors include Wen Xie, Hirdesh Uppal, Songrong Ren, David Toma, S. P. S. Saini, Haibiao Gong, Ronald M. Evans, Yonggong Zhai, Jie Zhou and Li Xu and has published in prestigious journals such as Journal of Biological Chemistry, Circulation Research and Hepatology.

In The Last Decade

Ying Mu

23 papers receiving 1.2k citations

Peers

Ying Mu

ONCOL

PHARM

SURGE

EDM

Meishu Xu United States

Cindy Kunne Netherlands

Kajsa P. Kanebratt Sweden

Diane Stroup United States

Xiulong Song United States

Mieko Iwahashi United States

Anke Geick Germany

Thomas B. Leonard United States

Wei‐Dong Chen China

Ann L. Craddock United States

Meishu Xu United States

Ying Mu

268 ×0.6

ONCOL

243 ×0.6

PHARM

518 ×1.4

231 ×0.7

SURGE

259 ×1.0

EDM

Citations per year, relative to Ying Mu Ying Mu (= 1×) peers Meishu Xu

Countries citing papers authored by Ying Mu

Since Specialization

Citations

This map shows the geographic impact of Ying Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Mu more than expected).

Fields of papers citing papers by Ying Mu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Mu. The network helps show where Ying Mu may publish in the future.

Co-authorship network of co-authors of Ying Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Mu. A scholar is included among the top collaborators of Ying Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Mu. Ying Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mu, Ying, et al.. (2023). Chemerin/CMKLR1 pathway exacerbates cisplatin-induced spiral ganglion neuron injury. Toxicological Research. 40(1). 73–81. 3 indexed citations

Tang, Song, Huiyun Chang, Yuanyuan Chen, et al.. (2021). Development of alveolar-capillary-exchange (ACE) chip and its application for assessment of PM2.5-induced toxicity. Ecotoxicology and Environmental Safety. 223. 112601–112601. 16 indexed citations

Mu, Ying, et al.. (2020). Evaluating emtricitabine + rilpivirine + tenofovir alafenamide in combination for the treatment of HIV-infection. Expert Opinion on Pharmacotherapy. 21(4). 389–397. 9 indexed citations

Hatami, Elham, Ying Mu, Subhash C. Chauhan, et al.. (2019). Mannose-decorated hybrid nanoparticles for enhanced macrophage targeting. Biochemistry and Biophysics Reports. 17. 197–207. 62 indexed citations

He, Hui, et al.. (2018). Polarized macrophage subsets differentially express the drug efflux transporters MRP1 and BCRP, resulting in altered HIV production. Antiviral chemistry & chemotherapy. 26. 2662864656–2662864656. 16 indexed citations

Cory, Theodore J., Ying Mu, Yuqing Gong, Sunitha Kodidela, & Santosh Kumar. (2018). Sofosbuvir + velpatasvir + voxilaprevir for the treatment of hepatitis C infection. Expert Opinion on Pharmacotherapy. 19(7). 749–757. 8 indexed citations

Mu, Ying, Sunitha Kodidela, Yujie Wang, Santosh Kumar, & Theodore J. Cory. (2018). The dawn of precision medicine in HIV: state of the art of pharmacotherapy. Expert Opinion on Pharmacotherapy. 19(14). 1581–1595. 13 indexed citations

Mu, Ying, Dianne E. Godar, & Stephen J. Merrill. (2017). A Perspective on the Challenges and Issues in Developing Biomarkers for Human Allergic Risk Assessments. Biomarkers in Medicine. 11(7). 523–526. 1 indexed citations

Hu, Jianping, Ziheng Hu, Yan Zhang, et al.. (2016). Metal binding mediated conformational change of XPA protein:a potential cytotoxic mechanism of nickel in the nucleotide excision repair. Journal of Molecular Modeling. 22(7). 156–156. 16 indexed citations

10.

Ouyang, Qin, Lirong Wang, Ying Mu, & Xiang‐Qun Xie. (2014). Modeling skin sensitization potential of mechanistically hard-to-be-classified aniline and phenol compounds with quantum mechanistic properties. BMC Pharmacology and Toxicology. 15(1). 76–76. 11 indexed citations

11.

Poloyac, Samuel M., Muzamil Ahmad, Ying Mu, et al.. (2008). Protective effect of a novel soluble epoxide hydrolase inhibitor 1471 on brain damage after temporary MCAO in rats. The FASEB Journal. 22(S1). 1 indexed citations

12.

Uppal, Hirdesh, S. P. S. Saini, Antonio Moschetta, et al.. (2007). Activation of LXRs prevents bile acid toxicity and cholestasis in female mice. Hepatology. 45(2). 422–432. 108 indexed citations

13.

Zhou, Jie, Yonggong Zhai, Ying Mu, et al.. (2006). A Novel Pregnane X Receptor-mediated and Sterol Regulatory Element-binding Protein-independent Lipogenic Pathway. Journal of Biological Chemistry. 281(21). 15013–15020. 301 indexed citations

14.

Saini, S. P. S., Ying Mu, Haibiao Gong, et al.. (2005). Dual role of orphan nuclear receptor pregnane X receptor in bilirubin detoxification in mice†. Hepatology. 41(3). 497–505. 70 indexed citations

15.

Gong, Haibiao, Shivendra V. Singh, Sharda P. Singh, et al.. (2005). Orphan Nuclear Receptor Pregnane X Receptor Sensitizes Oxidative Stress Responses in Transgenic Mice and Cancerous Cells. Molecular Endocrinology. 20(2). 279–290. 88 indexed citations

16.

Mu, Ying, Corey R. J. Stephenson, Christopher Kendall, et al.. (2005). A Pregnane X Receptor Agonist with Unique Species-Dependent Stereoselectivity and Its Implications in Drug Development. Molecular Pharmacology. 68(2). 403–413. 22 indexed citations

17.

He, Fengtian, Jiang Li, Ying Mu, et al.. (2005). Downregulation of Endothelin-1 by Farnesoid X Receptor in Vascular Endothelial Cells. Circulation Research. 98(2). 192–199. 126 indexed citations

18.

Saini, S. P. S., Junichiro Sonoda, Li Xu, et al.. (2004). A Novel Constitutive Androstane Receptor-Mediated and CYP3A-Independent Pathway of Bile Acid Detoxification. Molecular Pharmacology. 65(2). 292–300. 200 indexed citations

19.

Xie, Wen, Hirdesh Uppal, S. P. S. Saini, et al.. (2004). Orphan nuclear receptor-mediated xenobiotic regulation in drug metabolism. Drug Discovery Today. 9(10). 442–449. 87 indexed citations

20.

Azari, Kodi, Bruce Doll, Charles Sfeir, Ying Mu, & Jeffrey O. Hollinger. (2001). Therapeutic potential of bone morphogenetic proteins. Expert Opinion on Investigational Drugs. 10(9). 1677–1686. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact